Type 2 diabetes, fatty liver disease reversed in rats

A controlled-release oral therapy has been developed by scientists that reversed type 2 diabetes and fatty liver disease in rats, according to a study. “Given these promising results in animal models of NAFLD/NASH and type 2 diabetes we are pursuing additional preclinical safety studies to take this mitochondrial protonophore approach to the clinic” said the researchers. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *